196 related articles for article (PubMed ID: 8438493)
1. A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplant Proc; 1993 Feb; 25(1 Pt 1):809-12. PubMed ID: 8438493
[No Abstract] [Full Text] [Related]
2. Monoclonal antibodies against LFA-1 and VLA-4 inhibit graft vasculitis in rat cardiac allografts.
Paul LC; Davidoff A; Paul DW; Benediktsson H; Issekutz TB
Transplant Proc; 1993 Feb; 25(1 Pt 1):813-4. PubMed ID: 8438494
[No Abstract] [Full Text] [Related]
3. Prolongation in murine cardiac allograft survival with monoclonal antibodies to LFA-1, ICAM-1, and CD4.
Jendrisak M; Jendrisak G; Gamero J; Mohanakumar T
Transplant Proc; 1993 Feb; 25(1 Pt 1):825-7. PubMed ID: 8094914
[No Abstract] [Full Text] [Related]
4. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies.
Stepkowski SM; Tu Y; Condon TP; Bennett CF
Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822
[No Abstract] [Full Text] [Related]
5. Difference in immunosuppressive effects of antibodies to ICAM-1 and LFA-1 between hepatic and cardiac allografts.
Harihara Y; Sugawara Y; Inoue K; Kubota K; Bandai Y; Makuuchi M; Miyasaka M
Transplant Proc; 1996 Jun; 28(3):1368-9. PubMed ID: 8658698
[No Abstract] [Full Text] [Related]
6. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
7. Donor microchimerism is not responsible for the maintenance of tolerance to donor alloantigens in recipients tolerant of cardiac allografts.
Hamano K; Rawsthorne M; Bushell A; Morris PJ; Wood KJ
Transplant Proc; 1995 Feb; 27(1):151-2. PubMed ID: 7878951
[No Abstract] [Full Text] [Related]
8. Interaction between CD4 and CD8 T cells determines graft outcome in monoclonal antibody-treated mice.
Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):792-3. PubMed ID: 8438483
[No Abstract] [Full Text] [Related]
9. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
Isobe M; Ihara A
Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
[No Abstract] [Full Text] [Related]
10. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M
Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
[No Abstract] [Full Text] [Related]
11. Efficacy of anti-T-lymphocyte monoclonal antibody (5G2) therapy for prolongation of canine islet allograft survival.
Brendel MD; Schachner RS; Kong SS; Qian T; Alejandro R; Mintz DH
Transplant Proc; 1994 Apr; 26(2):743-4. PubMed ID: 8171637
[No Abstract] [Full Text] [Related]
12. Effect of anti-VCAM-1 and anti-VLA-4 monoclonal antibodies on cardiac allograft survival and response to soluble antigens in mice.
Isobe M; Suzuki J; Yagita H; Okumura K; Sekiguchi M
Transplant Proc; 1994 Apr; 26(2):867-8. PubMed ID: 7513478
[No Abstract] [Full Text] [Related]
13. Anti-CD4 monoclonal antibody-induced allograft survival is associated with a defect in interleukin-2-dependent T-cell activation.
Pearson TC; Hamano K; Morris PJ; Wood KJ
Transplant Proc; 1993 Feb; 25(1 Pt 1):786-7. PubMed ID: 8438480
[No Abstract] [Full Text] [Related]
14. Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation.
Suzuki J; Isobe M; Yamazaki S; Horie S; Okubo Y; Sekiguchi M
J Heart Lung Transplant; 1997 Nov; 16(11):1141-8. PubMed ID: 9402514
[TBL] [Abstract][Full Text] [Related]
15. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
Nakakura EK; McCabe SM; Zheng B; Shorthouse RA; Scheiner TM; Blank G; Jardieu PM; Morris RE
Transplantation; 1993 Feb; 55(2):412-7. PubMed ID: 8094583
[No Abstract] [Full Text] [Related]
16. Role of ICAM-1 and LFA-1 in cardiac allograft rejection of the rat.
Komori A; Nagata M; Ochiai T; Nakajima K; Hori S; Asano T; Isono K; Tamatani T; Miyasaka M
Transplant Proc; 1993 Feb; 25(1 Pt 1):831-2. PubMed ID: 8094916
[No Abstract] [Full Text] [Related]
17. Effects of exogenous IL-2 on tolerance induction by anti-ICAM-1 and anti-LFA-1 monoclonal antibodies.
Isobe M; Suzuki J; Yamazaki S; Sekiguchi M
Transplant Proc; 1996 Apr; 28(2):1045-6. PubMed ID: 8623222
[No Abstract] [Full Text] [Related]
18. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
19. A single administration of LFA-1 antibody confers prolonged allograft survival.
Talento A; Nguyen M; Blake T; Sirotina A; Fioravanti C; Burkholder D; Gibson R; Sigal NH; Springer MS; Koo GC
Transplantation; 1993 Feb; 55(2):418-22. PubMed ID: 7679531
[TBL] [Abstract][Full Text] [Related]
20. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
